Envista Holdings Corp
NYSE:NVSTMedical - Equipment & Services
+$0.76 today
- Market cap
- $3.81B
- Beta
- 0.89
- P/E (TTM)
- 62.0
- EPS (TTM)
- $0.41
Volume 1.92M
Average 2.94M
NVST EBITDA Margin
EBITDA as a percentage of revenue.
Envista Holdings CorpNYSE: NVST
EBITDA Margin · Q3 FY2026 · quarter ended Oct 2026
EBITDA Margin widens to 74.5%
EBITDA Margin was 74.5% in Q3 FY2026, up 61.4 pp from a year earlier. On a trailing-twelve-month basis it was 29.0%, up 16.5 pp year over year. Over 3 fiscal years it narrowed by 8.2 pp.
Context
- EBITDA Margin widened in 1 of the last 3 fiscal years.
What to watch
Whether EBITDA Margin reaches the consensus estimate from 11 analysts of 16.5% for the fiscal year ending Dec 2026, up from 12.1% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterOct 2026
- 74.5%+55.3 pp QoQ
- Last fiscal yearDec 2025
- 12.1%+1.0 pp YoY
- LTMOct 2026
- 29.0%+16.5 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +61.4 pp | +5.3 pp | -56.1 pp |
| 1 year | +1.0 pp | +4.4 pp | +3.4 pp |
| 3 years | -8.2 pp | +3.8 pp | +12.0 pp |
| 5 years | — | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 12.1%
- Year-over-year change
- +1.0pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 12.1% | +1.0pp |
| FY2024 | 2024-12-31 | 11.1% | -8.0pp |
| FY2023 | 2023-12-31 | 19.1% | -1.2pp |
| FY2022 | 2022-12-31 | 20.3% | -0.6pp |
| FY2021 | 2021-12-31 | 20.9% | — |
EBITDA Margin vs competitors
How NVST compares with its peers on the latest reported figures
- NVST's LTM Oct 2026 EBITDA Margin of 29.0% is the highest of the 9 companies compared; the peer median is -0.2%.
- Its year-over-year change of +16.5 pp is the 2nd highest of 9, against a peer median of +1.1 pp.
- Over three fiscal years its change of -8.2 pp compares with a peer median of +7.3 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Oct 2026 | 29.0% | +16.5 pp | -8.2 pp | |
CONConcentra Group Holdings Parent, Inc. | LTM Sep 2026 | 20.5% | +1.3 pp | -0.2 pp |
| LTM Jun 2026 | 11.5% | -2.1 pp | +5.5 pp | |
| LTM Jun 2026 | 2.9% | +0.9 pp | +3.6 pp | |
| LTM Mar 2026 | 1.6% | +2.9 pp | +9.1 pp | |
| LTM Jun 2026 | -1.9% | -26.9 pp | -17.1 pp | |
| LTM Mar 2026 | -3.5% | +10.1 pp | +15.6 pp | |
| LTM Mar 2026 | -75.2% | +1.0 pp | +105.9 pp | |
| LTM Jun 2026 | -226.4% | +86.1 pp | +801.0 pp | |
| FY2025 | — | — | — | |
| FY2025 | — | — | — | |
| Peer median (excluding NVST) | -0.2% | +1.1 pp | +7.3 pp | |
Competitors are the stored peer set for NVST. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 2.51B | 2.57B | 2.57B | 2.51B | 2.72B |
| Cost of Revenue | 1.05B | 1.08B | 1.12B | 1.12B | 1.22B |
| Gross Profit | 1.46B | 1.49B | 1.45B | 1.39B | 1.5B |
| Gross Margin | 58.3% | 57.9% | 56.5% | 55.4% | 55.0% |
| Research & Development | 100.5M | 100.1M | 93.8M | 99.1M | 114M |
| Selling, General & Admin | 989.5M | 1.03B | 1.03B | 1.14B | 1.16B |
| Operating Expenses | 1.16B | 1.17B | 1.42B | 2.43B | 1.27B |
| Depreciation & Amortization | 151.9M | 162.1M | 162.6M | 123.1M | 116M |
| EBITDA | 524.3M | 522M | 490M | 279.5M | 329.8M |
| EBITDA Margin | 20.9% | 20.3% | 19.1% | 11.1% | 12.1% |
| Operating Income | 306.2M | 319.2M | 31.5M | (1.04B) | 225.7M |
| Operating Margin | 12.2% | 12.4% | 1.2% | -41.4% | 8.3% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 54.1M | 38.4M | 63.4M | 46.4M | 36.6M |
| Other Income / Expenses | (51.7M) | (35.3M) | (86.4M) | (46.5M) | (48.5M) |
| Income Before Tax | 254.5M | 283.9M | (54.9M) | (1.08B) | 177.2M |
| Pre-Tax Margin | 10.1% | 11.1% | -2.1% | -43.2% | 6.5% |
| Income Tax Expense | (9M) | 45.9M | 45.3M | 33.9M | 130.2M |
| Net Income | 340.5M | 243.1M | (100.2M) | (1.12B) | 47M |
| Net Margin | 13.6% | 9.5% | -3.9% | -44.6% | 1.7% |
| EPS (Basic) | 1.63 | 1.46 | (0.60) | (6.50) | 0.28 |
| EPS (Diluted) | 1.48 | 1.34 | (0.60) | (6.50) | 0.28 |
| Weighted Avg Shares | 161.2M | 162.9M | 166.9M | 172.2M | 168M |
| Weighted Avg Shares (Diluted) | 177.6M | 177.6M | 166.9M | 172.2M | 169.2M |
Envista Holdings Corp
NYSE:NVST
Intrinsic Alpha fair value
Locked
Current Price
$23.75
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.